Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy.
Khanna R, Yu J, Yang X, Moutal A, Chefdeville A, Gokhale V, Shuja Z, Chew LA, Bellampalli SS, Luo S, François-Moutal L, Serafini MJ, Ha T, Perez-Miller S, Park KD, Patwardhan AM, Streicher JM, Colecraft HM, Khanna M.
Khanna R, et al. Among authors: chew la.
Pain. 2019 Jul;160(7):1644-1661. doi: 10.1097/j.pain.0000000000001524.
Pain. 2019.
PMID: 30933958
Free PMC article.